Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGoodRx Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 7 | $0.09 | $0.11 | $0.10 |
| Q2 2025 | 12 | $0.09 | $0.12 | $0.10 |
| Q3 2025 | 8 | $0.08 | $0.10 | $0.09 |
| Q4 2025 | 8 | $0.08 | $0.10 | $0.09 |
| Q1 2026 | 3 | $0.08 | $0.12 | $0.10 |
| Q2 2026 | 1 | $0.10 | $0.11 | $0.11 |
| Q3 2026 | 1 | $0.11 | $0.12 | $0.12 |
| Q4 2026 | 1 | $0.11 | $0.12 | $0.12 |
| Q1 2027 | 1 | $0.12 | $0.13 | $0.12 |
| Q2 2027 | 1 | $0.13 | $0.14 | $0.13 |
| Q3 2027 | 1 | $0.14 | $0.15 | $0.14 |
| Q4 2027 | 1 | $0.14 | $0.15 | $0.14 |
| Q1 2028 | 1 | $0.15 | $0.17 | $0.16 |
| Q2 2028 | 1 | $0.17 | $0.19 | $0.18 |
| Q3 2028 | 1 | $0.19 | $0.21 | $0.20 |
| Q4 2028 | 1 | $0.19 | $0.21 | $0.20 |
GoodRx Holdings, Inc. Earnings Date And Information
GoodRx Holdings, Inc. last posted its earnings results on Tuesday, November 4th, 2025. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The company had revenue of 196.03 M for the quarter and had revenue of 792.32 M for the year. GoodRx Holdings, Inc. has generated $0 earnings per share over the last year ($0.0418 diluted earnings per share) and currently has a price-to-earnings ratio of 22.86. GoodRx Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 26th, 2026 based on prior year's report dates.
GoodRx Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2025 | Q3 2025 | $0.09 | $0.00 | -0.09 | $194.54 M | $196.03 M |
| 08/06/2025 | Q2 2025 | $0.10 | $0.04 | -0.06 | $205.90 M | $203.07 M |
| 05/07/2025 | Q1 2025 | $0.09 | $0.03 | -0.06 | N/A | $202.97 M |
| 02/27/2025 | Q4 2024 | $0.10 | $0.02 | -0.08 | N/A | $198.58 M |
| 11/07/2024 | Q3 2024 | $0.09 | $0.03 | -0.06 | $195.66 M | $195.25 M |
| 08/08/2024 | Q2 2024 | $0.09 | $0.02 | -0.07 | $200.47 M | $200.61 M |
| 05/09/2024 | Q1 2024 | $0.09 | -$0.00 | -0.09 | N/A | $197.88 M |
| 02/29/2024 | Q4 2023 | $0.08 | -$0.06 | -0.14 | N/A | $196.64 M |
| 11/09/2023 | Q3 2023 | $0.06 | -$0.09 | -0.15 | $188.52 M | $179.96 M |
| 08/09/2023 | Q2 2023 | $0.06 | $0.14 | 0.08 | $186.84 M | $189.68 M |
| 05/10/2023 | Q1 2023 | $0.06 | -$0.01 | -0.07 | $182.09 M | $183.99 M |
| 02/28/2023 | Q4 2022 | N/A | -$0.00 | N/A | $178.50 M | $184.11 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.10 | N/A | $185.04 M | $187.32 M |
| 08/08/2022 | Q2 2022 | N/A | -$0.00 | N/A | $184.71 M | $191.80 M |
| 05/09/2022 | Q1 2022 | N/A | $0.03 | N/A | $200.45 M | $203.33 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.10 | N/A | $217.46 M | $213.26 M |
| 11/10/2021 | Q3 2021 | N/A | -$0.04 | N/A | $194.78 M | $195.10 M |
| 08/12/2021 | Q2 2021 | $0.08 | $0.08 | 0 | $174.58 M | $176.64 M |
| 05/13/2021 | Q1 2021 | N/A | $0.00 | N/A | $160.62 M | $160.43 M |
| 03/11/2021 | Q4 2020 | N/A | -$0.74 | N/A | $147.82 M | $153.54 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GoodRx Holdings, Inc. Earnings: FAQ's
GoodRx Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 26th, 2026 based offlast year's report dates.
The conference call for GoodRx Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for GoodRx Holdings, Inc.'s latest earnings report can be read online.
GoodRx Holdings, Inc. (:GDRX) has a recorded annual revenue of $792.32 M.
GoodRx Holdings, Inc. (:GDRX) has a recorded net income of $16.39 M.GoodRx Holdings, Inc. has generated $0.0425 earnings per share over the last four quarters.
GoodRx Holdings, Inc. (:GDRX) has a price-to-earnings ratio of 22.86 and price/earnings-to-growth ratio is 0.23.